Andere Kunden interessierten sich auch für
![Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers]( "Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers")
Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers101,99 €![Marine Carotenoids in Inflammation and Cancer]( "Marine Carotenoids in Inflammation and Cancer")
Marine Carotenoids in Inflammation and Cancer72,99 €![Marine Natural Products as Anticancer Agents]( "Marine Natural Products as Anticancer Agents")
Marine Natural Products as Anticancer Agents59,99 €![Anticancer Inhibitors]( "Anticancer Inhibitors")
Anticancer Inhibitors80,99 €![Novel Aspects of COVID-19 after a Two-Year Pandemic]( "Novel Aspects of COVID-19 after a Two-Year Pandemic")
Novel Aspects of COVID-19 after a Two-Year Pandemic72,99 €![Emerging and Re-Emerging Diseases-Novel Challenges in Today's World]( "Emerging and Re-Emerging Diseases-Novel Challenges in Today's World")
Emerging and Re-Emerging Diseases-Novel Challenges in Today's World59,99 €![Novel Medical and General Hebrew Terminology from the 13th Century: Volume 4]( "Novel Medical and General Hebrew Terminology from the 13th Century: Volume 4")
Novel Medical and General Hebrew Terminology from the 13th Century: Volume 4160,99 €
Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original and review articles devoted to key areas of major progress and expectations. Key Features: Nanoparticle-based drug delivery in cancer therapy; Nanoerythrosomes; Cancer immunotherapy; Therapeutic vaccines; Oncogenic and tumor suppressive components of the cell cycle; Antimitotics in cancer clinical trials; Multifunctional enzymes as anti-cancer drug targets; Targeting undruggable proteins and non-coding RNAs; Cell-penetrating peptides; Repurposed cancer drugs in clinical trials; Circulating tumour cells.